We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMB icon
326
Williams Companies
WMB
$85.8B
$3.93M 0.03%
116,591
-9,271
-7% -$316K
CAG icon
327
Conagra Brands
CAG
$7.42B
$3.92M 0.03%
142,826
+92
+0.1% +$2.84K
PRU icon
328
Prudential Financial
PRU
$42.6B
$3.91M 0.03%
41,239
-1,227
-3% -$116K
SNOW icon
329
Snowflake
SNOW
$98.1B
$3.9M 0.03%
25,818
+1,739
+7% +$283K
TRV icon
330
Travelers Companies
TRV
$81.1B
$3.83M 0.03%
23,451
-856
-4% -$143K
LH icon
331
Labcorp
LH
$25.2B
$3.81M 0.03%
18,934
-2,985
-14% -$630K
EHC icon
332
Encompass Health
EHC
$11.3B
$3.76M 0.03%
56,000
– –
TGT icon
333
Target
TGT
$66.3B
$3.72M 0.03%
33,930
+139
+0.4% +$17.6K
USB icon
334
US Bancorp
USB
$97.9B
$3.7M 0.03%
112,143
+13,450
+14% +$490K
XRAY icon
335
Dentsply Sirona
XRAY
$2.84B
$3.68M 0.03%
107,769
+10,212
+10% +$388K
WELL icon
336
Welltower
WELL
$173B
$3.66M 0.03%
44,714
+4
+0% +$329
K
337
DELISTED
Kellanova
K
$3.65M 0.03%
69,616
+5
+0% +$297
IR icon
338
Ingersoll Rand
IR
$33.1B
$3.62M 0.03%
56,848
-9,875
-15% -$657K
HDB icon
339
HDFC Bank
HDB
$123B
$3.6M 0.03%
122,000
+62,000
+103% +$2.02M
ATVI
340
DELISTED
Activision Blizzard
ATVI
$3.56M 0.03%
38,141
-19,131
-33% -$1.75M
INVH icon
341
Invitation Homes
INVH
$17.9B
$3.56M 0.03%
112,318
+11,264
+11% +$387K
DAWN
342
DELISTED
Day One Biopharmaceuticals
DAWN
$3.56M 0.03%
290,014
– –
VC icon
343
Visteon
VC
$2.85B
$3.55M 0.03%
25,711
-11,841
-32% -$1.71M
LNG icon
344
Cheniere Energy
LNG
$54.2B
$3.51M 0.02%
21,143
-525
-2% -$84.7K
AXSM icon
345
Axsome Therapeutics
AXSM
$11.7B
$3.5M 0.02%
50,084
– –
AGCO icon
346
AGCO
AGCO
$8.41B
$3.49M 0.02%
29,501
+12,197
+70% +$1.55M
SNDX icon
347
Syndax Pharmaceuticals
SNDX
$1.7B
$3.48M 0.02%
240,010
– –
SWTX
348
DELISTED
SpringWorks Therapeutics
SWTX
$3.48M 0.02%
150,626
– –
PSX icon
349
Phillips 66
PSX
$82.9B
$3.48M 0.02%
28,984
+3,343
+13% +$375K
ETNB
350
DELISTED
89bio
ETNB
$3.4M 0.02%
220,000
– –
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.